Author name: Robert Carter

Home Caffeine Blog Big Pharma Targets Women ECT Device Lethal? Chemical Imbalance Is Evil? ECT’s La La Land No Chemical Imbalance? Real Reason ECT Works? The Ethics of ECT Evaluate ECT with Common Sense. The Psychiatric Lie of “Schizophrenia” Defer the FDA Bribery into the Future New FDA Ban of Mini-Electroshock Device Shows Hypocrisy Dangerous Side Effects of Antidepressant Zoloft No Child Left Unmedicated When Is a Diagnosis Not a Diagnosis Involuntary Psychiatric Commitment A Brutal Political Tool So What’s Wrong, Really, with Feeling Sadness or Anxiety? Telehealth Statistics Highlight Psychiatry’s Reliance on Opinion, NotFact, to Treat Their Patients Psychiatrists Cannot Adhere to Informed Consent Laws Psychiatry Turns Asylums into Inhumane Centers of Profit Fear Sells. So Does Irresponsibility Big Pharma Makes the Guns Can Anyone Trust “FDA Approval” for Antidepressants? Big Pharma: Follow the Money, Not the Morality You’re Worth More Sick or Crazy than Healthy Psychiatric Drugs and Going Postal Youth Suicides After Rx Free Books, DVDs, etc Order form Other Resources Latest News Control, Not Cure Lucrative Crosspollination Antidepressants Put Women at Risk for Osteoporosis & Bone Fractures Penalties a Small Price to Pay for Big Pharma’s Fat Cats Suicides Occur as FDA Takes 2 Decades to Rule on Dangers of Singulair $267 Million Settlement against Acadia Psychiatric Hospitals Not Enough to Change Their Evil Ways NZ Government Apologizes for Fifty Years of Psychiatric Institution Abuse Innocent CT Woman Locked Up For False Diagnosis of Schizophrenia Reno Psychiatrist’s Remedy for Patient’s Suicide Attempt Antidepressant Clinical Trials by Pharma Companies Skew Efficiency Results Big Pharma Covert Marketing Win America’s Psychiatric Hospitals: Exploitation for Profit Gustavo Kinrys Sentenced for $19 Million Insurance Fraud Florida Finally Follows WHO and UN Call for Ban of ECT on Children A.D.H.D. Executives Accused of $100 Million Adderall Fraud Michigan Psych Patients Committed Involuntarily for Medicaid Profits Contact Us Home Caffeine Blog Big Pharma Targets Women ECT Device Lethal? Chemical Imbalance Is Evil? ECT’s La La Land No Chemical Imbalance? Real Reason ECT Works? The Ethics of ECT Evaluate ECT with Common Sense. The Psychiatric Lie of “Schizophrenia” Defer the FDA Bribery into the Future New FDA Ban of Mini-Electroshock Device Shows Hypocrisy Dangerous Side Effects of Antidepressant Zoloft No Child Left Unmedicated When Is a Diagnosis Not a Diagnosis Involuntary Psychiatric Commitment A Brutal Political Tool So What’s Wrong, Really, with Feeling Sadness or Anxiety? Telehealth Statistics Highlight Psychiatry’s Reliance on Opinion, NotFact, to Treat Their Patients Psychiatrists Cannot Adhere to Informed Consent Laws Psychiatry Turns Asylums into Inhumane Centers of Profit Fear Sells. So Does Irresponsibility Big Pharma Makes the Guns Can Anyone Trust “FDA Approval” for Antidepressants? Big Pharma: Follow the Money, Not the Morality You’re Worth More Sick or Crazy than Healthy Psychiatric Drugs and Going Postal Youth Suicides After Rx Free Books, DVDs, etc Order form Other Resources Latest News Control, Not Cure Lucrative Crosspollination Antidepressants Put Women at Risk for Osteoporosis & Bone Fractures Penalties a Small Price to Pay for Big Pharma’s Fat Cats Suicides Occur as FDA Takes 2 Decades to Rule on Dangers of Singulair $267 Million Settlement against Acadia Psychiatric Hospitals Not Enough to Change Their Evil Ways NZ Government Apologizes for Fifty Years of Psychiatric Institution Abuse Innocent CT Woman Locked Up For False Diagnosis of Schizophrenia Reno Psychiatrist’s Remedy for Patient’s Suicide Attempt Antidepressant Clinical Trials by Pharma Companies Skew Efficiency Results Big Pharma Covert Marketing Win America’s Psychiatric Hospitals: Exploitation for Profit Gustavo Kinrys Sentenced for $19 Million Insurance Fraud Florida Finally Follows WHO and UN Call for Ban of ECT on Children A.D.H.D. Executives Accused of $100 Million Adderall Fraud Michigan Psych Patients Committed Involuntarily for Medicaid Profits Contact Us From Bad to Worse: Innocent Connecticut Woman Locked up for Eight Months, Given a False Psychiatric Diagnosis of Schizophrenia Robert Carter/November 10, 2024      A Connecticut woman was arrested and incarcerated in the state’s highest security mental health institution after having insufficient ID to show a motel clerk at the Microtel Inn in Montville. She then refused to identify herself to the police officers the clerk had called.      She is not legally required to do so.      The motel clerk had called the police and said that the woman would not leave the premises and that she had used rude language toward him. When the police arrived, they found her sitting on a bench in the lobby sipping coffee. She refused to give the officers her name or show them any identification and she was arrested, handcuffed, and taken to the station.      Because refusing to identify oneself is not a crime, she was charged here with interfering with an officer and refusing to be fingerprinted. Bond was set at $500.00 and when she could not pay that, she was locked up.      During a number of court appearances she underwent over the next month, she insisted she had done nothing wrong. Nevertheless, Superior Court Judge Jassette A. Henry raised her bail to $50,000. She was then involuntarily committed to the state’s highest security mental health institution, despite the fact she had never shown any impulse to harm herself or anyone else.      She was then diagnosed with schizophrenia because of her “disorganized and tangential thinking that was loose in that it switched from topic to topic irrelevantly and quickly” and her inability to understand her legal situation.      “No, I understand I’m under false arrest,” she said. “I understand I am under false arrest.”      Psychotropic medication was recommended for her. When she resisted taking it, she was taken to probate court by the mental health facility, placed under a conservatorship, and an order was issued for forced involuntary medication.      Eight months later, in June, 2024, newly appointed defense lawyer Michael Brown had a private psychiatric evaluation done on his client. It found her to be competent.      The defense attorney filed a “public interest” appeal. Twenty days later the woman was finally released from custody.      Brown pointed out that “she was never wrong about the core constitutional question

Home Caffeine Blog Big Pharma Targets Women ECT Device Lethal? Chemical Imbalance Is Evil? ECT’s La La Land No Chemical Imbalance? Real Reason ECT Works? The Ethics of ECT Evaluate ECT with Common Sense. The Psychiatric Lie of “Schizophrenia” Defer the FDA Bribery into the Future New FDA Ban of Mini-Electroshock Device Shows Hypocrisy Dangerous Side Effects of Antidepressant Zoloft No Child Left Unmedicated When Is a Diagnosis Not a Diagnosis Involuntary Psychiatric Commitment A Brutal Political Tool So What’s Wrong, Really, with Feeling Sadness or Anxiety? Telehealth Statistics Highlight Psychiatry’s Reliance on Opinion, NotFact, to Treat Their Patients Psychiatrists Cannot Adhere to Informed Consent Laws Psychiatry Turns Asylums into Inhumane Centers of Profit Fear Sells. So Does Irresponsibility Big Pharma Makes the Guns Can Anyone Trust “FDA Approval” for Antidepressants? Big Pharma: Follow the Money, Not the Morality You’re Worth More Sick or Crazy than Healthy Psychiatric Drugs and Going Postal Youth Suicides After Rx Free Books, DVDs, etc Order form Other Resources Latest News Control, Not Cure Lucrative Crosspollination Antidepressants Put Women at Risk for Osteoporosis & Bone Fractures Penalties a Small Price to Pay for Big Pharma’s Fat Cats Suicides Occur as FDA Takes 2 Decades to Rule on Dangers of Singulair $267 Million Settlement against Acadia Psychiatric Hospitals Not Enough to Change Their Evil Ways NZ Government Apologizes for Fifty Years of Psychiatric Institution Abuse Innocent CT Woman Locked Up For False Diagnosis of Schizophrenia Reno Psychiatrist’s Remedy for Patient’s Suicide Attempt Antidepressant Clinical Trials by Pharma Companies Skew Efficiency Results Big Pharma Covert Marketing Win America’s Psychiatric Hospitals: Exploitation for Profit Gustavo Kinrys Sentenced for $19 Million Insurance Fraud Florida Finally Follows WHO and UN Call for Ban of ECT on Children A.D.H.D. Executives Accused of $100 Million Adderall Fraud Michigan Psych Patients Committed Involuntarily for Medicaid Profits Contact Us Home Caffeine Blog Big Pharma Targets Women ECT Device Lethal? Chemical Imbalance Is Evil? ECT’s La La Land No Chemical Imbalance? Real Reason ECT Works? The Ethics of ECT Evaluate ECT with Common Sense. The Psychiatric Lie of “Schizophrenia” Defer the FDA Bribery into the Future New FDA Ban of Mini-Electroshock Device Shows Hypocrisy Dangerous Side Effects of Antidepressant Zoloft No Child Left Unmedicated When Is a Diagnosis Not a Diagnosis Involuntary Psychiatric Commitment A Brutal Political Tool So What’s Wrong, Really, with Feeling Sadness or Anxiety? Telehealth Statistics Highlight Psychiatry’s Reliance on Opinion, NotFact, to Treat Their Patients Psychiatrists Cannot Adhere to Informed Consent Laws Psychiatry Turns Asylums into Inhumane Centers of Profit Fear Sells. So Does Irresponsibility Big Pharma Makes the Guns Can Anyone Trust “FDA Approval” for Antidepressants? Big Pharma: Follow the Money, Not the Morality You’re Worth More Sick or Crazy than Healthy Psychiatric Drugs and Going Postal Youth Suicides After Rx Free Books, DVDs, etc Order form Other Resources Latest News Control, Not Cure Lucrative Crosspollination Antidepressants Put Women at Risk for Osteoporosis & Bone Fractures Penalties a Small Price to Pay for Big Pharma’s Fat Cats Suicides Occur as FDA Takes 2 Decades to Rule on Dangers of Singulair $267 Million Settlement against Acadia Psychiatric Hospitals Not Enough to Change Their Evil Ways NZ Government Apologizes for Fifty Years of Psychiatric Institution Abuse Innocent CT Woman Locked Up For False Diagnosis of Schizophrenia Reno Psychiatrist’s Remedy for Patient’s Suicide Attempt Antidepressant Clinical Trials by Pharma Companies Skew Efficiency Results Big Pharma Covert Marketing Win America’s Psychiatric Hospitals: Exploitation for Profit Gustavo Kinrys Sentenced for $19 Million Insurance Fraud Florida Finally Follows WHO and UN Call for Ban of ECT on Children A.D.H.D. Executives Accused of $100 Million Adderall Fraud Michigan Psych Patients Committed Involuntarily for Medicaid Profits Contact Us Reno Psychiatrist’s Remedy for Patient’s Suicide Attempt: Sex. With Him.      By Robert Carter/October 28, 2024      Per the Psych Search website, the Nevada State Board of Medical Examiners filed a complaint this August against Psychiatrist Abdollah Assad for having sex with a suicidal patient.      Assad had been treating his thirty-one year old female patient for a history of “anxiety and problematic relationships” according to the complaint. In 2020 the patient was staying in a motel and she contacted Assad and said she had attempted suicide. The psychiatrist did not immediately tell her ““to go to an emergency room, call an ambulance, or call police,” as he legally and ethically was obligated to do.      Instead, he went to her motel, picked her up, and took her to another motel and “engaged in sexual intercourse with her.” The complaint notes that he did this despite being aware of her “troublesome relationships in the past and her obvious fragile state” at that time.      Afterward he continued to prescribe Adderall for her.      Assad is charged with six counts: malpractice; influencing a patient to engage in sexual activity; engaging in sexual activity with a patient; unsafe or unprofessional conduct; terminating medical care without adequate notice to a patient; and violation of patient trust and exploitation of physician and patient relationship for financial or personal gain.      A second complaint was also presented by the Board of Medical Examiners against Assad for improperly prescribing controlled substances to a thirty-three year old male patient in 2019 and 2022.      For that crime Assad is charged with malpractice; failure to complete medical records; terminating medical care without adequate notice to a patient; violation of standards of practice, violations of model policy; and violations of standards of practice established by regulation as well as with unreasonable additional fees for a lab test.      The PsychSearch.net website that this article appeared in recently is a compendium of crimes committed by psychiatrists internationally in their practices based on the public records that are available and the media reports of them. One can search lists on the site by country or, in America, by state. One can also search the site country by country or state by state to easily see if a particular psychiatrist is under current investigation or has been

Home Caffeine Blog Big Pharma Targets Women ECT Device Lethal? Chemical Imbalance Is Evil? ECT’s La La Land No Chemical Imbalance? Real Reason ECT Works? The Ethics of ECT Evaluate ECT with Common Sense. The Psychiatric Lie of “Schizophrenia” Defer the FDA Bribery into the Future New FDA Ban of Mini-Electroshock Device Shows Hypocrisy Dangerous Side Effects of Antidepressant Zoloft No Child Left Unmedicated When Is a Diagnosis Not a Diagnosis Involuntary Psychiatric Commitment A Brutal Political Tool So What’s Wrong, Really, with Feeling Sadness or Anxiety? Telehealth Statistics Highlight Psychiatry’s Reliance on Opinion, NotFact, to Treat Their Patients Psychiatrists Cannot Adhere to Informed Consent Laws Psychiatry Turns Asylums into Inhumane Centers of Profit Fear Sells. So Does Irresponsibility Big Pharma Makes the Guns Can Anyone Trust “FDA Approval” for Antidepressants? Big Pharma: Follow the Money, Not the Morality You’re Worth More Sick or Crazy than Healthy Psychiatric Drugs and Going Postal Youth Suicides After Rx Free Books, DVDs, etc Order form Other Resources Latest News Control, Not Cure Lucrative Crosspollination Antidepressants Put Women at Risk for Osteoporosis & Bone Fractures Penalties a Small Price to Pay for Big Pharma’s Fat Cats Suicides Occur as FDA Takes 2 Decades to Rule on Dangers of Singulair $267 Million Settlement against Acadia Psychiatric Hospitals Not Enough to Change Their Evil Ways NZ Government Apologizes for Fifty Years of Psychiatric Institution Abuse Innocent CT Woman Locked Up For False Diagnosis of Schizophrenia Reno Psychiatrist’s Remedy for Patient’s Suicide Attempt Antidepressant Clinical Trials by Pharma Companies Skew Efficiency Results Big Pharma Covert Marketing Win America’s Psychiatric Hospitals: Exploitation for Profit Gustavo Kinrys Sentenced for $19 Million Insurance Fraud Florida Finally Follows WHO and UN Call for Ban of ECT on Children A.D.H.D. Executives Accused of $100 Million Adderall Fraud Michigan Psych Patients Committed Involuntarily for Medicaid Profits Contact Us Home Caffeine Blog Big Pharma Targets Women ECT Device Lethal? Chemical Imbalance Is Evil? ECT’s La La Land No Chemical Imbalance? Real Reason ECT Works? The Ethics of ECT Evaluate ECT with Common Sense. The Psychiatric Lie of “Schizophrenia” Defer the FDA Bribery into the Future New FDA Ban of Mini-Electroshock Device Shows Hypocrisy Dangerous Side Effects of Antidepressant Zoloft No Child Left Unmedicated When Is a Diagnosis Not a Diagnosis Involuntary Psychiatric Commitment A Brutal Political Tool So What’s Wrong, Really, with Feeling Sadness or Anxiety? Telehealth Statistics Highlight Psychiatry’s Reliance on Opinion, NotFact, to Treat Their Patients Psychiatrists Cannot Adhere to Informed Consent Laws Psychiatry Turns Asylums into Inhumane Centers of Profit Fear Sells. So Does Irresponsibility Big Pharma Makes the Guns Can Anyone Trust “FDA Approval” for Antidepressants? Big Pharma: Follow the Money, Not the Morality You’re Worth More Sick or Crazy than Healthy Psychiatric Drugs and Going Postal Youth Suicides After Rx Free Books, DVDs, etc Order form Other Resources Latest News Control, Not Cure Lucrative Crosspollination Antidepressants Put Women at Risk for Osteoporosis & Bone Fractures Penalties a Small Price to Pay for Big Pharma’s Fat Cats Suicides Occur as FDA Takes 2 Decades to Rule on Dangers of Singulair $267 Million Settlement against Acadia Psychiatric Hospitals Not Enough to Change Their Evil Ways NZ Government Apologizes for Fifty Years of Psychiatric Institution Abuse Innocent CT Woman Locked Up For False Diagnosis of Schizophrenia Reno Psychiatrist’s Remedy for Patient’s Suicide Attempt Antidepressant Clinical Trials by Pharma Companies Skew Efficiency Results Big Pharma Covert Marketing Win America’s Psychiatric Hospitals: Exploitation for Profit Gustavo Kinrys Sentenced for $19 Million Insurance Fraud Florida Finally Follows WHO and UN Call for Ban of ECT on Children A.D.H.D. Executives Accused of $100 Million Adderall Fraud Michigan Psych Patients Committed Involuntarily for Medicaid Profits Contact Us Study Shows Funding of Antidepressant Clinical Trials by Pharmaceutical Companies Skews Efficiency Results Robert Carter/October 19, 2024      This month the University of Chicago Press published the results of an Ohio State University study that shows that the source of funding for a clinical trial influences the reported efficacy of the drug being tested. Those trials funded by antidepressant and antipsychotic pharmaceutical manufacturers show their own product on an average to be 49 percent more effective than identically conducted studies funded by independent entities.      “The funding interests of a given drug can explain almost half of the relative efficacy of that drug,” Tamar Oostrom, the author of the study, writes.      Pharmaceutical company sponsored trials for their own products show their drugs are 43 percent more likely to produce statistically significant improvements in the well being of their trial participants, compared to identically run trials sponsored by a research facility other than the manufacturer or its marketing agent.      A full 73 percent of these pharmaceutical manufacturer sponsored trials also show that their drug is more efficient than any competitor’s comparable product. Of course, that then results in greater sales.      How can this occur? It boils down to two main variables in the conduct of the trials. First, a company sponsored trial is one that is much more likely to be published. Therefore, its effect on the market is greater than those unpublished trials that show less beneficial outcomes to trials of the antidepressant’s manufacturer. Those “other” outcomes then remain hidden from the medical industry and from the public in their unpublished obscurity.      In other words, the published trials take on a greater validity merely because they are the ones that are most prominently displayed to the medical and the general public through their appearance in respectable medical journals.      Second, the clinical trial designs for company sponsored and independently sponsored tests can be different, although each is supposedly scientifically based. The length of the trial, the drug’s dosage, and the demographics of the tested population (that is, age, gender, severity of diagnosis, etc.) can be different from sponsored to unsponsored trials and still be scientifically “valid.”      However, the manipulation of those parameters allows sufficient wiggle room for potentially quite different trial outcomes. Oostrom calls his findings the “sponsorship effect.” Per his study, that

Home Caffeine Blog Big Pharma Targets Women ECT Device Lethal? Chemical Imbalance Is Evil? ECT’s La La Land No Chemical Imbalance? Real Reason ECT Works? The Ethics of ECT Evaluate ECT with Common Sense. The Psychiatric Lie of “Schizophrenia” Defer the FDA Bribery into the Future New FDA Ban of Mini-Electroshock Device Shows Hypocrisy Dangerous Side Effects of Antidepressant Zoloft No Child Left Unmedicated When Is a Diagnosis Not a Diagnosis Involuntary Psychiatric Commitment A Brutal Political Tool So What’s Wrong, Really, with Feeling Sadness or Anxiety? Telehealth Statistics Highlight Psychiatry’s Reliance on Opinion, NotFact, to Treat Their Patients Psychiatrists Cannot Adhere to Informed Consent Laws Psychiatry Turns Asylums into Inhumane Centers of Profit Fear Sells. So Does Irresponsibility Big Pharma Makes the Guns Can Anyone Trust “FDA Approval” for Antidepressants? Big Pharma: Follow the Money, Not the Morality You’re Worth More Sick or Crazy than Healthy Psychiatric Drugs and Going Postal Youth Suicides After Rx Free Books, DVDs, etc Order form Other Resources Latest News Control, Not Cure Lucrative Crosspollination Antidepressants Put Women at Risk for Osteoporosis & Bone Fractures Penalties a Small Price to Pay for Big Pharma’s Fat Cats Suicides Occur as FDA Takes 2 Decades to Rule on Dangers of Singulair $267 Million Settlement against Acadia Psychiatric Hospitals Not Enough to Change Their Evil Ways NZ Government Apologizes for Fifty Years of Psychiatric Institution Abuse Innocent CT Woman Locked Up For False Diagnosis of Schizophrenia Reno Psychiatrist’s Remedy for Patient’s Suicide Attempt Antidepressant Clinical Trials by Pharma Companies Skew Efficiency Results Big Pharma Covert Marketing Win America’s Psychiatric Hospitals: Exploitation for Profit Gustavo Kinrys Sentenced for $19 Million Insurance Fraud Florida Finally Follows WHO and UN Call for Ban of ECT on Children A.D.H.D. Executives Accused of $100 Million Adderall Fraud Michigan Psych Patients Committed Involuntarily for Medicaid Profits Contact Us Home Caffeine Blog Big Pharma Targets Women ECT Device Lethal? Chemical Imbalance Is Evil? ECT’s La La Land No Chemical Imbalance? Real Reason ECT Works? The Ethics of ECT Evaluate ECT with Common Sense. The Psychiatric Lie of “Schizophrenia” Defer the FDA Bribery into the Future New FDA Ban of Mini-Electroshock Device Shows Hypocrisy Dangerous Side Effects of Antidepressant Zoloft No Child Left Unmedicated When Is a Diagnosis Not a Diagnosis Involuntary Psychiatric Commitment A Brutal Political Tool So What’s Wrong, Really, with Feeling Sadness or Anxiety? Telehealth Statistics Highlight Psychiatry’s Reliance on Opinion, NotFact, to Treat Their Patients Psychiatrists Cannot Adhere to Informed Consent Laws Psychiatry Turns Asylums into Inhumane Centers of Profit Fear Sells. So Does Irresponsibility Big Pharma Makes the Guns Can Anyone Trust “FDA Approval” for Antidepressants? Big Pharma: Follow the Money, Not the Morality You’re Worth More Sick or Crazy than Healthy Psychiatric Drugs and Going Postal Youth Suicides After Rx Free Books, DVDs, etc Order form Other Resources Latest News Control, Not Cure Lucrative Crosspollination Antidepressants Put Women at Risk for Osteoporosis & Bone Fractures Penalties a Small Price to Pay for Big Pharma’s Fat Cats Suicides Occur as FDA Takes 2 Decades to Rule on Dangers of Singulair $267 Million Settlement against Acadia Psychiatric Hospitals Not Enough to Change Their Evil Ways NZ Government Apologizes for Fifty Years of Psychiatric Institution Abuse Innocent CT Woman Locked Up For False Diagnosis of Schizophrenia Reno Psychiatrist’s Remedy for Patient’s Suicide Attempt Antidepressant Clinical Trials by Pharma Companies Skew Efficiency Results Big Pharma Covert Marketing Win America’s Psychiatric Hospitals: Exploitation for Profit Gustavo Kinrys Sentenced for $19 Million Insurance Fraud Florida Finally Follows WHO and UN Call for Ban of ECT on Children A.D.H.D. Executives Accused of $100 Million Adderall Fraud Michigan Psych Patients Committed Involuntarily for Medicaid Profits Contact Us Big Pharma Covert Marketing Win: SAMHSA Lauds Biden’s $68.5 Million Grant for Mental Health Services Robert Carter/October 4, 2024      The Substance Abuse and Mental Health Services Administration (SAMHSA) applauded last month the Biden Administration grants of $68.5 million for behavioral health education, training and community programs.      SAMHSA has been one of the chief suppliers of mental health statistics to Mental Health America, which bills itself as the nation’s leading national non-profit dedicated to the promotion of mental health, well-being, and illness prevention. Mental Health America asserts that 20 percent of Americans experience mental health issues, but that 56 percent of those people do not receive any treatment for their condition.      Those statistics are frequently quoted in the media to show the mental health epidemic the country is now facing. Keeping people in fear is standard fare for the media, of course, but these statistics are also used to make Big Pharma’s myriad medications to “solve” this problem seem more essential, even given the Black Box warnings of their suicidal side effects.      But where do those SAMHSA statistics about the nation’s mental health come from?      Since the Covid years, a good portion of them come from short, on-line screening questionnaires that people can take to see if they are suffering from depression or anxiety, among other mental health issues. The nine brief questions they are asked are of the “In the last two weeks have you felt noticeably sad about an event in your life?” format.      These questions for each of the SAMHSA screening forms were written by psychiatrist Robert L. Spitzer of Columbia University and his third wife, Janet Williams, now Professor Emerita of Clinical Psychiatric Social Work at Columbia University. The funding for their work was through a grant to Columbia by Pfizer, the manufacturer of Zoloft and the first Big Pharma company to broadly advertise the now debunked “chemical imbalance” theory as a cause of mental illness.      Pfizer also financed the British screening questionnaire now used by the National Health Service on people to see – some would say “suggest” – the possibility of a mental illness condition.      Biden’s $68.5 million dollar grant can now help usher into the mental health treatment industry those screened candidates who have self-diagnosed as having emotional stress. The 56 percent of untreated American respondents then become